Skip to main content
Equibles

Soleus Capital Management, L.P.

Position in IMUX — Immunic, Inc.

CIK 1802630 GREENWICH, CT
Back to IMUX Full portfolio

Position in IMUX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$6,916,500
+$1,921,500 QoQ
Shares Held
450,000
0.0% QoQ
Ownership
3.30%
of shares outstanding
% of Portfolio
0.24%
of 13F equity value
Holder Rank
#10
of 55 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in IMUX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Soleus Capital Management, L.P. holds $1,753,981,438 across 64 Biotechnology names. IMUX ranks #45 (0.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 KRYS
Krystal Biotech, Inc.
 939,254 $349,092,534
2 CELC
Celcuity Inc.
 1,704,318 $178,305,749
3 TGTX
Tg Therapeutics, Inc.
 2,927,895 $160,858,551
4 RIGL
Rigel Pharmaceuticals Inc
 1,843,504 $72,117,876
5 VCEL
Vericel Corp
 1,459,152 $64,917,672
6 PRAX
Praxis Precision Medicines, Inc.
 177,517 $59,430,916
7 GERN
Geron Corp
 42,808,659 $54,795,083
8 ERAS
Erasca, Inc.
 2,700,000 $49,464,000

All Filings in IMUX

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $6,916,500 450,000
2026-03-31 $4,995,000 4,500,000
2025-09-30 $1,393,566 1,580,007
2025-06-30 $5,090,518 7,293,007
2025-03-31 $7,949,377 7,293,007
2024-12-31 $7,293,007 7,293,007
2024-09-30 $12,033,461 7,293,007
2024-06-30 $8,095,237 7,293,007
2024-03-31 $9,626,769 7,293,007
2023-12-31 $450,000 300,000
2023-09-30 $441,000 300,000
2023-06-30 $753,000 300,000
2023-03-31 $447,000 300,000
2022-09-30 $758,400 240,000
2022-06-30 $832,800 240,000
2022-03-31 $2,712,000 240,000
2021-12-31 $1,674,750 175,000